The transcription factor ZBED6 acts as a repressor of Igf2 and affects directly or indirectly the 17 transcriptional regulation of thousands of genes. Here, we use gene editing in mouse C2C12 18 myoblasts and show that ZBED6 regulates Igf2 exclusively through its binding site 5′- 3′ in intron 1 of Igf2. Deletion of this motif (Igf2 Δ GGCT ) or complete ablation of Zbed6 leads to 20 ~20-fold up-regulation of IGF2 protein. Quantitative proteomics revealed an activation of Ras 21 signaling pathway in both Zbed6 -/and Igf2 Δ GGCT myoblasts, and a significant enrichment of 22 mitochondrial membrane proteins among proteins showing altered expression in Zbed6 -/-23 myoblasts. Both Zbed6 -/and Igf2 Δ GGCT myoblasts showed a faster growth rate and developed 24 myotube hypertrophy. These cells exhibited an increased O 2 consumption rate, due to IGF2 up-25 regulation. Transcriptome analysis revealed ~30% overlap between differentially expressed 26 genes in Zbed6 -/and Igf2 Δ GGCT myotubes, with an enrichment of up-regulated genes involved in 27 muscle development. In contrast, ZBED6-overexpression in myoblasts led to cell apoptosis, cell 28 cycle arrest, reduced mitochondrial activities and ceased myoblast differentiation. The 29 similarities in growth and differentiation phenotypes observed in Zbed6 -/and Igf2 Δ GGCT 30
INTRODUCTION 38 39
The ZBED6 transcription factor is unique to placental mammals and has evolved from a 40 domesticated DNA transposon located in the first intron of ZC3H11A, a zinc-finger protein with 41 RNA-binding capacity ( Markljung et al., 2009; Younis et al., 2018a) . ZBED6 was identified as a 42 repressor of insulin-like growth factor 2 (IGF2) expression following the identification of a 43 mutation in IGF2 intron 3 in domestic pigs (Van Laere et al., 2003; Markljung et al., 2009 ). This 44 mutation disrupts a ZBED6 binding site and leads to a 3-fold increase in IGF2 mRNA 45 expression in pig skeletal muscle, which in turn results in increased muscle mass and reduced 46 subcutaneous fat deposition. We have previously reported that ZBED6 has thousands of putative 47 binding sites in human and mouse genomes, with a strong enrichment in the vicinity of 48 transcription start sites (TSS) of genes involved in development and transcriptional regulation 49 it is still unknown which of these genes, besides Igf2, are true functional targets of ZBED6. 51
Silencing of Zbed6 expression in mouse C2C12 myoblasts using small interfering RNA (siRNA) 52 resulted in differential expression of about 700 genes, including a 3-fold up-regulation of Igf2 53 mRNA (Jiang et al., 2014) . IGF2 is an essential growth factor in skeletal muscle development 54 and has a role in the initiation of myoblast differentiation (Florini et al., 1991) . Recently, we 55 have developed Zbed6 -/and Igf2 knock-in mice, the latter carrying the pig mutation at the 56 ZBED6 binding site. These mice exhibited increased body weight and skeletal muscle growth 57 (Younis et al., 2018b) . However, the molecular mechanism how ZBED6 affects muscle growth 58 has not been fully investigated. Particularly, the interaction between ZBED6 and Igf2 during 59 detected 381 and 196 genes to be DE in both SILAC and RNA-seq in Zbed6 -/and Igf2 Δ GGCT 151 myoblasts, respectively. Moreover, we found a significant positive correlation between DE genes 152 and proteins in Zbed6 -/-(r=0.49) and Igf2 Δ GGCT (r=0.55) myoblasts ( Figure 3A) . Strikingly, the 153 dramatic up-regulation of Igf2 was detected in both Zbed6 -/and Igf2 Δ GGCT myoblasts at both the 154 transcriptome and proteome level ( Figure 3A) . 155
In order to distinguish between the DE genes caused by ZBED6 inactivation and those 156 that are secondary due to Igf2 up-regulation, we calculated the overlap between DE genes and 157 proteins in both Zbed6 -/and Igf2 Our previous ChIP-seq analysis for ZBED6 identified thousands of putative target genes 168 in C2C12 myoblasts (Markljung et al., 2009; Jiang et al., 2014) . Here, we combined the SILAC, 169
RNA-seq and ChIP-seq data to find out functional targets for ZBED6. The previously described 170
ChIP-seq peaks in C2C12 cells were associated with about 3,000 genes, i.e. about 15% of the 171 genes in the mouse genome. As many as 1,001 of the about 4,000 proteins (25%) detected in the 172 significant overrepresentation (P<0.001) is consistent with the notion that ZBED6 binds open 174 chromatin (Jiang et al., 2014) . Since 25% of the proteins detected by SILAC corresponded to a 175 gene associated with a ChIP-seq peak it is expected that 25% (95) of the 381 genes detected as 176 differentially expressed both at the mRNA and protein level due to chance only. We found 98 177 genes in our data ( Figure 3D, left) . This implies that we cannot draw any firm conclusion on true 178 ZBED6 targets in mouse C2C12 cells, other than the well-established Igf2 locus, based on these 179 data. In fact, Igf2 is the gene showing the most striking differentially expressed gene between 180 WT and Zbed6 -/cells ( Figure 3D , right). However, five other genes, highlighted in Figure 3D , 181 showed a striking up-regulated expression after silencing of the ZBED6 repressor suggesting that 182 they may be functional targets. The gene ontology (GO) analysis of the transcripts with 183 significant up-regulation in Zbed6 -/myoblasts and associated with ChIP-seq peaks showed a 184 significant enrichment for proteins involved in cellular response to insulin stimulus ( Figure 3E ). 185
These genes include Insulin Like Growth Factor 1 Receptor (Igf1r), Phosphoinositide-3-Kinase 186
Regulatory Subunit 1 (Pik3r1), and Ectonucleotide pyrophosphatase phosphodiesterase 1 187 (ENPP1), a negative modulator of insulin receptor (IR) activation. 188 189 ZBED6 modulates transcriptional regulation of differentiated myotubes partially through 190
IGF2 signaling 191
To investigate the possible role of the ZBED6-Igf2 axis on transcriptional regulation during 192 myogenesis, we performed transcriptome analyses of Zbed6 -/-, Igf2 Δ GGCT and WT cells after 193 differentiation into myotubes. First, we analyzed the differentially expressed (DE) genes in WT 194 myoblasts vs. myotubes to explore the overall transcriptional changes during myotube formation. 195
The counting of aligned reads using the STAR tool (Dobin et al., 2013) identified ~12,000 expressed genes in myoblasts with at least one read count per million (cpm) ( Figure S3A ). The 197 expression of ~3,900 genes was found to be changed significantly, with 2,200 up-regulated and 198 1,700 down-regulated after differentiation into myotubes (P<0.05, after Benjamini-Hochberg 199 correction for multiple testing), ( Figure S3B ). GO analysis of up-regulated genes revealed a 200 significant enrichment of cell adhesion, muscle proteins and muscle contraction genes, while the 201 down-regulated genes were enriched for cell cycle and mitotic nuclear division categories 202 ( Figure S3C ). 203
Transcriptome analysis comparing WT and Zbed6 -/cells after differentiation identified 204 2,673 DE genes (log fold change >0.5; P<0.05, after Benjamini-Hochberg correction for 205 multiple testing), with 1,243 up-regulated and 1,430 down-regulated genes. Furthermore, 2,630 206 genes showed a significant differential expression in the comparison of Igf2 Δ GGCT and WT cells 207 after differentiation, with 1,278 up-regulated and 1,352 down-regulated in mutant cells (Table  208 S4). The dissection of the DE genes based on the direction of the change revealed a highly 209 significant 30% overlap between DE genes in Zbed6 -/and Igf2 Δ GGCT myotubes ( Figure 4A ). 210
The expression of Igf2 is known to be upregulated during myoblast differentiation 211 (Florini et al., 1991) . In this study, we detected the same pattern as Igf2 was up-regulated 100-212 fold after differentiation of WT cells ( Figure 4B ). Furthermore, the Igf2 mRNA expression was 213 up-regulated 500-fold in Zbed6 -/and Igf2 Δ GGCT myotubes in comparison to WT myoblast and 6-214 fold in comparison to WT myotubes ( Figure 4B ). Interestingly, this up-regulation of Igf2 215 expression was accompanied with a significant but modest increase in the expression of the 216 endogenous Zbed6 mRNA ( Figure 4C ), which indicates a positive correlation between Igf2 and 217 Zbed6 expression. 218 12 chain 3 (Myh3) ( Figure 5B, figure S4 ). The GO analysis of down-regulated genes showed a 242 significant enrichment of muscle-specific genes, while the up-regulated genes were primarily 243 related to cell cycle regulation and cell division (Table 1) , thus the opposite trend compared with 244
Zbed6 -/cells. As many as 463 genes were significantly down-regulated in differentiated ZBED6-245 OE myoblasts and significantly up-regulated in Zbed6 -/myotubes ( Figure 5C ). These represents 246 about 40% of the up-regulated genes in Zbed6 -/myotubes. We examined these genes and the 247 corresponding pathways in more detail. The GO analysis revealed a striking enrichment in 248 muscle-specific categories (Table S5 ). Among the enriched KEGG pathways, we found cardiac 249 muscle contraction, hypertrophic cardiomyopathy (HCM), and calcium, insulin and AMPK 250 signaling (Table S5) . We examined the genes present in the AMPK and insulin signaling 251 pathways and compared their expression in Zbed6 -/-, Igf2 Δ GGCT and ZBED6-OE cells after 252 differentiation. Interestingly, the key components of these pathways were found to be up-253 regulated in Igf2 Δ GGCT myotubes as well ( Figure 5D ). For instance, the expression of 254 phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (Pik3cb), glycogen 255 synthase 1 (Gys1) and AMP-activated protein kinase alpha2 (Prkaa2), beta2 (Prkab2) and 256 gamma3 (Prkag3) subunits were found to be up-regulated in Zbed6 -/and Igf2 Δ GGCT myotubes, 257 and down-regulated in ZBED6-OE differentiated cells ( Figure 5D ). Activation of the PI3K 258 pathway and its downstream targets plays a central role in myogenesis. Interestingly, Prkaa2, 259
Prkab2 and Prkag3, all up-regulated in Zbed6 -/and Igf2 Δ GGCT myotubes, encode the α 2, β 2 and 260 γ 3 subunits. These subunits form a specific isoform of AMPK that shows tissue-specific 261 expression in white skeletal muscle (Barnes et al., 2004) . The results imply that the interaction 262 between ZBED6-Igf2 has an essential role in muscle development and influences muscle 263 metabolism.
265

Over-expression of ZBED6 in non-differentiated C2C12 cells results in reduced cell 266 viability and cell cycle arrest 267
Since deletion of ZBED6 promotes cell proliferation and myogenesis, we investigated whether 268 over-expression of ZBED6 causes the opposite effect. Unfortunately, we did not succeed in our 269 attempts to establish a stable myoblast cell line overexpressing ZBED6 suggesting that 270 overexpression may be lethal in C2C12 cells, which is consistent with the results of a previous 271 study (Butter et al., 2010) . Therefore, we measured cell viability after transient overexpression of 272 ZBED6 (ZBED6-OE) in C2C12 cells. We found a significant reduction in cell viability in 273 ZBED6-OE cells in comparison to control cells ( Figure S5 ). The cell apoptosis analysis using 274 flow cytometry revealed a significant reduction in the number of live cells in ZBED6-OE ( Figure  275 6A). Moreover, cell cycle analysis using flow cytometry displayed a significant difference in the 276 proportion of cells in different cell cycle phases, in which 82% of ZBED6-OE cells appeared to 277 be in G0/G1 phase and 10% in S-phase, whereas the corresponding proportions in control cells 278 were 58% and 35%, respectively ( Figure 6B ). These phenotypic changes in ZBED6-OE 279 myoblasts were in complete agreement with the RNA-seq analysis that revealed a significant 280 enrichment of genes involved in cell cycle and cell division processes among the down-regulated 281 genes after ZBED6-OE in proliferating myoblasts ( Table 2) Figure 6C ). Some of the putative direct targets with essential 284 role in cell cycle regulation were validated by qPCR ( Figure S6) . These included the genes for 285 E2f1 and E2f2, members of the E2f family that has an essential role in regulating cell 286 striking upregulation of genes involved in immune defense after ZBED6-OE in proliferating 288 myoblasts ( Table 2 ). These results suggest that ZBED6 inhibits proliferation and promotes 289 immune defense in C2C12 cells. that occurs during mesenchymal differentiation is driven by the transcription factor PGC-1α, and 296 IGF2 has been suggested to participate in this process (Lee et al., 2015) . Moreover, RNA-seq 297 and SILAC proteomic analyses showed a significant enrichment for mitochondrial membrane 298 proteins among DE proteins in Zbed6 -/myoblasts ( Figure 3C ). These observations encouraged 299 us to look closer at mitochondrial activities in response to ZBED6-overexpression or ablation. 300
Flow cytometry analysis of MitoTracker Red intensity, a dye that labels active mitochondria in 301 living cells, indicated a significant reduction in mitochondrial mass in ZBED6-OE cells and an 302 increase in mitochondria in Zbed6 -/cells, while no change was observed in Igf2 Δ GGCT cells 303 ( Figure 6D and 6E). As MitoTracker Red labeling only gives a very crude estimate of 304 mitochondrial mass and activity, we also stained transiently ZBED6-GFP transfected C2C12 305 cells with JC-1, a probe that gives an estimate of the inner mitochondrial membrane potential. 306
These experiments demonstrated that ZBED6-GFP overexpressing cells displayed lower JC-1 307 aggregates (red fluorescence) to JC-1 monomers (green fluorescence) ratio ( Figure 6F and 6G), 308 indicating a decreased mitochondrial membrane potential in response to overexpressed ZBED6. 309
Both the MitoTracker and JC-1 experiments are in agreement with the SILAC data, and suggest an inhibitory role of ZBED6 on mitochondrial mass/function. Since both Zbed6 -/and Igf2 Δ GGCT 311 myoblasts exhibited similar phenotypic characteristics regarding growth and differentiation, we 312 explored another part of mitochondrial function in these cells. We analyzed C2C12 cell 313 mitochondrial oxidation rates (OCR) using the Seahorse technique (Malmgren et al., 2009 ). The 314 OCR and extracellular acidification rate (ECAR) assay revealed an increased OCR ( Figure 6H , 315 left) and reduced ECAR in Zbed6 -/and Igf2 Δ GGCT myoblasts ( Figure 6H , right) compared to WT 316 cells. OCR and ECAR were unaffected in ZBED6-OE cells ( Figure 6H ). As both Zbed6 -/and 317 Igf2 Δ GGCT myoblasts show increased Igf2 expression, we hypothesized that the increase in 318 respiration might be an IGF2 effect. To test this hypothesis, we treated cells with recombinant 319 IGF2 and measured the OCR and ECAR dose-response in C2C12 WT cells. We found a 2-fold 320 increase in respiration rates at the higher IGF2 concentrations (20 and 40 ng/ml IGF2) ( Figure 6I , 321 left), while no changes were detected in the extracellular acidification rates ( Figure 6I , right). 322
Thus, it appears that ZBED6 controls myoblast mitochondrial biogenesis/activity partially via 323 IGF2. 324
325
DISCUSSION 326
This study conclusively demonstrates that the interaction between ZBED6 and its binding site in 327
Igf2 plays a critical role in regulating the development of myogenic cells. This conclusion is 328 based on (i) MS quantitative proteomics and transcriptomic analyses, (ii) the altered growth rate 329 of myoblasts, (iii) effects on myotube formation and maturation, and (iv) assessment of 330 mitochondrial activities. Interestingly, the disruption of the ZBED6 binding site in Igf2 was 331 sufficient to obtain very similar phenotypic effects as observed in the Zbed6 knock out 332 demonstrating that the phenotypic effects caused by Zbed6 inactivation in myoblast cells are 333 largely mediated through the regulation of Igf2 expression. 334
The initial development of skeletal muscle occurs prenatally and involves the 335 proliferation of myoblasts, which then exit the cell cycle and start differentiation to form 336 myotubes (Dunglison et al., 1999; Stockdale, 1992) . It has been reported that the number of 337 myoblasts prenatally greatly influences muscle growth postnatally since the number of muscle 338 fibers are fixed at birth (Rehfeldt et al., 1993; Velloso, 2008) . This is of particular interest, since 339 ZBED6 inactivation or disruption of the interaction between ZBED6 and the binding site in Igf2 340 promotes the proliferation and growth of myoblasts ( Figure 1E including genes encoding myosin heavy and light chains, troponins, titin, myomesins, alpha actinin, leiomodin, and myoglobin. Interestingly, ~40% of the up-regulated DE genes in Zbed6 -/-356 myotubes were found to be down-regulated in differentiated C2C12 cells after overexpressing 357 ZBED6. The GO analysis of those genes showed an enrichment in muscle-specific categories 358
very similar to what we found among up-regulated genes in Zbed6 -/myotubes. 359 SILAC quantitative proteomic analysis of mutant myoblasts revealed a significant 360 enrichment of mitochondrial membrane proteins exclusively among the DE proteins found in 361 Figure 3C ). This observation was confirmed by the 362 decreased mitochondrial membrane potential in response to ZBED6 overexpression ( Figure 6D Furthermore, it has been indicated that the basal mitochondrial respiration rate was increased 372 one-fold and the maximal respiration increased four-fold in differentiated myotubes (Remels et 373 al., 2010) . 374
We have previously reported that ZBED6 has ~2,500 binding sites all over the genome 375 The re-quantify option was enabled to get ratios where only one isotope pattern was found. 500
Match between runs was also enabled, to identify peptides where only MS1 data was available. 501
Minimum label ratio count was set to 2, and the advanced ratio estimation option was enabled. 502
Peak lists were searched against the UniProtKB/Swiss-Prot Mus musculus proteome database 503 (UP000000589, version 2016-01-12) with a maximum of two trypsin miscleavages per peptide. 504
The contaminants database of MaxQuant was also utilized. A decoy search was made against the 505 reversed database, where the peptide and protein false discovery rates were both set to 1%. Only 506 proteins identified with at least two peptides of at least 7 amino acids in length were considered 507 reliable. The peptide output from MaxQuant was filtered by removing reverse database hits, 508 potential contaminants and proteins only identified by site (PTMs). Intensity values were first 509 normalized using variance stabilization method, adjusted for batch effect and fitted to linear 510 model (Huber et al., 2002; Ritchie et al., 2015) . The empirical Bayes moderated t-statistics and 511 their associated P-values were used to calculate the significance of DE proteins (Smyth, 2004) . 512
The P-values were corrected for multiple testing using the Benjamini-Hochberg procedures 513 (Benjamini and Hochberg, 1995). 514 515 RNA sequencing. Myoblasts or the collected myotubes were washed in PBS and total RNA was 516 extracted using the RNeasy Mini kit (QIAGEN). The RNA quality and integrity was measured 517 with a RNA ScreenTape assay (TapeStation, Agilent Technologies). Strand-specific, 3′ end 518 mRNA sequencing libraries were generated using QuantSeq 3′ mRNA-Seq Library Prep Kit 519 (Lexogen) following the manufacturer's instructions. For each sample, 2 µg of total RNA were 520 poly-A selected using oligo-dT beads to enrich for mRNA, and the RNA-seq libraries were 521 amplified by 12 PCR cycles. The libraries were size-selected for an average insert size of 150 bp 522 and sequenced as 50 bp paired-end reads using Illumina HiSeq. Sequence reads were mapped to 523 the reference mouse genome (mm10) using STAR 2.5. 
